Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
initial public offering
Podcast
A closer look at European biotech investment in 2024
This week on “The Top Line,” we explore the European biotech investment landscape.
Ayla Ellison
,
James Waldron
Mar 22, 2024 8:43am
Kyverna raises IPO expectations to almost $300M
Feb 6, 2024 9:46am
Gene editing biotech Metagenomi plans modest $87M IPO
Feb 5, 2024 9:14am
Alto, Fractyl head to public markets with IPOs north of $100M
Feb 2, 2024 8:14am
Kyverna eyes $180M IPO haul to fund autoimmune CAR-T trials
Feb 1, 2024 9:45am
Optimism at Jefferies, but don't expect IPO boost soon—Sofinnova
Nov 16, 2023 3:00am